Adrenoleukodystrophy: Leriglitazone Halts Early Cerebral Forms
· 11 December 2024
In this study, we demonstrate that leriglitazone can stop neuroinflammation and halt disease progression in most men with cerebral adrenoleukodystrophy.
In this study, we demonstrate that leriglitazone can stop neuroinflammation and halt disease progression in most men with cerebral adrenoleukodystrophy.